Veloxis Pharmaceuticals
Arun Changolkar, PhD, MBA, MSc has extensive experience in the pharmaceutical industry, specializing in areas such as Health Economics and Outcomes Research, Real-World Evidence Generation, and Market Access. Arun'sprofessional journey includes roles at companies like Veloxis Pharmaceuticals, Emergent BioSolutions, EMD Serono, and GlaxoSmithKline. Arun has held positions ranging from Director to Associate Director, showcasing their expertise in supporting various developmental and marketed products in the healthcare sector.
Arun Changolkar holds a Bachelor of Science in Chemistry, Zoology, and Botany from Osmania University (1983-1986). Arun completed a Master of Science in Applied (Organic) Chemistry from Jawaharlal Nehru Technological University (1988-1992). Arun then pursued a Doctor of Philosophy in Cancer Research (Biochemistry) at Osmania University (1996-1999). Arun went on to be a Post Doctoral Fellow in Cancer Research at Harvard University (1998-1999) and later at University of Pennsylvania in Cardiovascular Epigenetics, Urology, and Diabetic Research (2000-2007). Arun also obtained a Master of Business Administration from the Fox School of Business at Temple University (2003-2007).
This person is not in any offices
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®.